Executive Summary
This digest covers 50 filings from August 21, 2026, revealing a market bifurcated between aggressive corporate restructuring and a wave of micro-cap distress. The most critical theme is a deluge of Nasdaq non-compliance notices, with 14 companies receiving deficiency warnings for low bid prices, insufficient equity, or delinquent filings, signaling a potential wave of micro-cap delistings.
Concurrently, there is significant M&A and restructuring activity, including a $180M SPAC merger for Everli Global, a major insolvency admission for Satiate Agri Ltd (₹6.27 Cr default), and the final deregistration of QVC Group post-bankruptcy. Insider activity was limited, but a notable promoter acquisition in Orissa Bengal Carrier and a related-party acquisition by KPI Green Energy highlight specific capital allocation moves. The overarching theme is one of cleansing: distressed micro-caps face existential threats while larger entities pursue strategic consolidation and new ventures, creating a high-risk, high-opportunity environment for event-driven investors.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K
Tracking the trend? Catch up on the prior Global High-Priority Regulatory Events digest from August 20, 2026.
Investment Signals (10)
-
SPAC merger values Everli at $180M, but $30M PIPE is unsecured and the deal requires shareholder approval. The 30-vote super-voting Class B shares (sunsetting in 12 years) create a governance red flag for minority holders.
-
Subsidiary acquiring 100% of DMGEL for ₹55.8 Cr via CCPS. DMGEL's revenue surged 7x from ₹30.6 Cr to ₹213.98 Cr in two years, but it's a related-party deal (promoter holds 8.95%) and the company has a short operating history since Nov 2021. [BULLISH on growth, BEARISH on governance]
-
NCLT approved amalgamation with Silverleaf Capital (appointed date Oct 1, 2023). The merger aims to create synergy and a stronger tech backbone, but the significantly ante-dated appointed date (over a year before filing) is a regulatory red flag that was challenged. [BULLISH on strategy, BEARISH on execution risk]
-
Sold SimpliDerm for up to $11M ($8M cash upfront) to fund NXT-41x launch in a $1.5B market. This non-dilutive capital extends runway through 2028, but the company is now dependent on a single product with regulatory clearance not expected until H1 2027. [BULLISH on capital allocation, BEARISH on commercial risk]
- Orissa Bengal Carrier Limited ↓ (BULLISH)▲
Promoter group acquired 56,675 shares (0.267% of equity) via open market over three days. While small, consistent insider buying at current levels signals promoter confidence.
- Glen Industries Limited ↓ (NEUTRAL)▲
Promoter group (Lalit Agrawal HUF) acquired 9,600 shares at ₹121.50, increasing stake from 74.17% to 74.21%. A very small, routine purchase, but at a premium to potential market price, indicating no distress selling.
-
Tender offer by argenx at $77/share. Guggenheim fairness opinion uses a DCF with a -50% terminal growth rate post-2043 loss of exclusivity, implying the offer fully captures terminal value. Shareholder lawsuits alleging omitted info create a potential for a higher bid or settlement. [BULLISH for arbitrageurs, BEARISH for holdouts]
-
Board to consider merging 74.86%-owned subsidiary TPL Plastech. This simplifies the corporate structure and could unlock value for minority holders of TPL Plastech, who would receive TTL shares. [BULLISH for TPL Plastech minority]
- Veranda Learning Solutions Limited ↓ (BULLISH)▲
NCLT sanctioned a composite scheme to demerge and list its commerce education business (J.K. Shah). 100% shareholder approval and a clear catalyst (listing of new entity) create a value-unlocking event.
-
Received delisting notice for failing to meet $35M MVLS. Has requested a hearing, staying the Aug 27 suspension. The stock is a high-risk binary event play on the panel's decision.
Risk Flags (10)
- Satiate Agri Ltd / Insolvency↓ [HIGH RISK]▼
NCLT admitted CIRP for a ₹6.27 Cr default. The company admitted the debt but sought 6 months to repay, which was rejected. This signals immediate and total loss for equity holders.
- Gangotri Textiles Ltd / Insolvency↓ [HIGH RISK]▼
NCLT admitted voluntary CIRP for ₹240.46 Cr in debt, with defaults dating back to 2005. Assets were sold in 2015, leaving zero revenue. Equity is effectively worthless.
- QVC Group, Inc. / Deregistration↓ [HIGH RISK]▼
Filed Form 15 to terminate SEC reporting after Chapter 11 plan cancelled all stock. This is the final nail in the coffin for equity holders, who were wiped out.
- Silexion Therapeutics Corp / Delisting↓ [HIGH RISK]▼
Received delisting notice for shareholders' equity of only $44,000 (requirement: $2.5M). The company is under a mandatory monitor and does not meet any alternative standard. Appeal deadline is Aug 25, 2026. Imminent delisting risk.
- Dragonfly Energy Holdings Corp / Delisting↓ [HIGH RISK]▼
Negative equity of $(184,000) as of June 30, 2026. Failed all three Nasdaq equity standards. Has 45 days to submit a plan, but the fundamental equity deficit is severe.
- ▼
Received its THIRD Nasdaq notice in 2026 (late filing, low bid price, low MVLS). Effected a 1-for-12 reverse split on Aug 13, but cumulative distress signals a high probability of delisting.
- urban-gro, Inc. / Immediate Suspension↓ [HIGH RISK]▼
Nasdaq Staff determined immediate suspension due to improper listing application process after a reverse merger. Trading to be suspended Aug 26, 2026. The company is appealing, but the stock faces imminent illiquidity.
- authID Inc. / Going Concern Risk↓ [HIGH RISK]▼
Stockholders' equity of $2.04M is below the $2.5M requirement. The filing explicitly mentions 'substantial doubt about going concern,' highlighting a severe capital deficiency.
- Adial Pharmaceuticals, Inc. / Equity Deficiency↓ [HIGH RISK]▼
Failed to meet $2.5M equity requirement. Plans to convert Series A Preferred to regain compliance, but this would massively dilute common shareholders.
- ▼
Filed 8-K for a completed acquisition but disclosed zero details on target, size, or consideration. This lack of transparency is a major red flag for a small-cap company.
Opportunities (9)
- Forte Biosciences, Inc. / Merger Arbitrage↓ (OPPORTUNITY)◆
Tender offer at $77/share. With nine shareholder demand letters alleging omitted info, there is a non-zero chance of a bump or settlement. The DCF analysis with a -50% terminal growth rate suggests the offer is full, but legal pressure could create a short-term trading opportunity.
- KPI Green Energy Limited / Growth via IBC↓ (OPPORTUNITY)◆
Acquiring DMGEL, which grew revenue from ₹30.6 Cr to ₹213.98 Cr in two years, at a valuation of ₹55.8 Cr. If the growth trajectory continues, the acquisition could be highly accretive.
- TPL Plastech Limited / Merger Arbitrage↓ (OPPORTUNITY)◆
Parent Time Technoplast (74.86% holder) proposes to merge TPL into itself. Minority holders of TPL will receive TTL shares, potentially at a favorable ratio if the merger unlocks synergies.
- Veranda Learning Solutions Limited / Spin-off Value↓ (OPPORTUNITY)◆
NCLT approved demerger of J.K. Shah Commerce Education. The new listed entity could command a higher valuation multiple as a pure-play education stock, unlocking value for VLS shareholders.
- Elutia Inc. / Product Catalyst↓ (OPPORTUNITY)◆
Divestiture provides non-dilutive capital to launch NXT-41x in a $1.5B market. Regulatory clearance expected H1 2027. If successful, the stock could re-rate significantly from current distressed levels.
-
Trading at a potential discount to the $10 trust value if the deal fails. The $30M PIPE is unsecured, creating uncertainty. If the deal closes, early investors could see upside; if it fails, the floor is the trust value. [OPPORTUNITY for risk-arb]
- Share India Securities Limited / Synergy Realization↓ (OPPORTUNITY)◆
The amalgamation with Silverleaf Capital (a tech company) is expected to provide a stronger technology backbone. If executed well, this could improve margins and cross-selling opportunities.
- ◆
Received 'no adverse observation' from BSE for its merger with Radical Bio-Organics. This de-risks the deal and moves it closer to completion, potentially unlocking value.
- Axita Cotton Limited / IBC Acquisition↓ (OPPORTUNITY)◆
Filed EOI to acquire Varidhi Cotspin (29,184 spindles capacity) via CIRP. Acquiring assets through insolvency can be done at distressed valuations, offering significant upside if the turnaround succeeds.
Sector Themes (5)
- Micro-Cap Delisting Wave◆
14 companies received Nasdaq/NYSE deficiency notices on a single day (Aug 21, 2026). The primary causes are low stock prices (bid price <$1) and insufficient shareholders' equity (<$2.5M). This suggests a broad-based liquidity and capital crisis among micro-cap listed companies, likely exacerbated by a risk-off environment. Investors should avoid holding these names without a clear catalyst.
- Indian Corporate Restructuring Surge◆
A significant number of filings involve Indian companies undergoing M&A, amalgamations, or insolvency processes (e.g., Share India, Veranda Learning, Satiate Agri, Gangotri Textiles). This indicates a period of active corporate cleanup and consolidation in the Indian market, driven by the IBC and NCLT processes.
- SPAC and De-SPAC Distress◆
The Everli Global S-4 highlights the ongoing challenges in the SPAC market, with an unsecured PIPE and complex governance structures. Meanwhile, companies that went public via SPAC (e.g., Rain Enhancement, TruGolf) are now facing delisting, showing the post-merger performance struggles of many de-SPACs.
- Biotech Cash Runway Crisis◆
Multiple biotech companies (Silexion, Pasithea, Estrella, Adial) are facing delisting due to low equity and bid prices. This reflects a sector-wide challenge where early-stage biotechs are burning cash without revenue, and the market is unwilling to fund them at current levels. Elutia's asset sale is a textbook example of how these companies are trying to survive.
- Related-Party Transaction Scrutiny◆
Several M&A filings involve related-party transactions (KPI Green Energy, Time Technoplast, Grasim/Hindalco/UltraTech JV). While these can be strategically sound, they require close scrutiny for minority shareholder value destruction, especially when valuations are supported by a single registered valuer's report.
Watch List (8)
-
Appeal deadline Aug 25, 2026. The company has only $44k in equity. The Nasdaq panel decision will determine if the stock survives or is immediately delisted. High-impact binary event.
-
Trading suspension scheduled for Aug 26, 2026. The company is requesting a hearing by Aug 26. The stock's liquidity will be destroyed if the suspension holds. Monitor for hearing outcome.
-
Nasdaq hearing requested to appeal delisting. Suspension was scheduled for Aug 27 but is stayed. The panel's decision on continued listing relief is the key catalyst.
-
Board meeting on Aug 26, 2026, to consider the merger proposal. The swap ratio and strategic rationale will be critical for TPL Plastech minority shareholders.
-
Joint Venture and Share Purchase Agreement for 30% stake in HL Klemove India Pvt Ltd. Transaction closing scheduled for Aug 24, 2026. Monitor for any last-minute changes or regulatory hurdles.
-
The S-4 registration statement must be declared effective by the SEC. Monitor for SEC comments and the shareholder vote date. The $30M PIPE's status is a key variable.
-
Has three simultaneous Nasdaq deficiency deadlines (bid price: Aug 31, late filing: Oct 19, MVLS: Dec 21). Failure on any one could trigger delisting. A high-stakes multi-front battle.
-
The company has emerged from Chapter 11 and deregistered. Monitor for the new entity's potential re-listing or private sale, which could provide a recovery for old debt holders.
Filing Analyses
(50)
21-08-2026
Melar Acquisition Corp. I filed an S-4 registration statement for its business combination with Everli Global Inc., valuing Everli at $180 million. The combined entity, New Melar, will issue up to 33.7 million Class A shares, 7.8 million Class B shares (with 30 votes per share, sunsetting after 12 years), and 14.5 million warrants. However, the transaction is subject to shareholder approval and SEC effectiveness, and includes a $10 million bridge financing that has been satisfied via notes with a 10% OID, as well as a potential $30 million PIPE investment that is not yet secured.
- · The Domestication will reincorporate Melar from Cayman Islands to Nevada before the Merger.
- · Class B common stock carries 30 votes per share, with super voting rights sunsetting 12 years after Closing.
- · 1,500,000 Escrow Shares will be held for 24 months post-Closing and subject to forfeiture upon specified events.
- · The Bridge Financing target of $10M was exceeded with $11,111,111 in aggregate principal notes (including 10% OID).
- · Yorkville agreed to provide up to $10M in convertible promissory notes under the Yorkville Note Purchase Agreement.
21-08-2026
The filing reports the completion of an acquisition by RocketFuel Blockchain, Inc. on August 21, 2026, under Item 2.01 of Form 8-K. However, the filing does not disclose the target company, deal size, consideration type, or any financial metrics. Without these critical details, the transaction cannot be evaluated for strategic rationale, valuation, or shareholder impact.
21-08-2026
S V Global Mill Limited has scheduled a Board Meeting on August 28, 2026, to consider and approve a scheme of arrangement for the cancellation of physical shares held in a suspense account. The scheme will be filed with NCLT Chennai and BSE for necessary approvals. No financial figures or performance metrics were disclosed in this filing.
- · Board Meeting date: August 28, 2026
- · Meeting will be held via Video Conferencing
- · Deemed venue: Registered Office at New No.5/1 (Old No.3/1), 6th Cross Street, CIT Colony, Mylapore, Chennai- 600 004
- · Scheme of arrangement relates to cancellation of physical shares held in Suspense Account
21-08-2026
Capricorn Systems Global Solutions Ltd has received a 'no adverse observation' letter from BSE Limited dated August 20, 2026, regarding its proposed Scheme of Amalgamation with Radical Bio-Organics Limited (Transferor Company). This regulatory clearance is a key milestone for the merger, which was initially approved by the Board on April 11, 2026, and remains subject to other applicable approvals.
- · The Observation Letter was received on August 20, 2026, and the company informed the exchange on August 21, 2026.
- · The Scheme is proposed under Sections 230–232 of the Companies Act, 2013.
- · The company's scrip code is 512169 and its CIN is L52510TG1985PLC043347.
- · The registered office is in Hyderabad, Telangana.
21-08-2026
Reliance Communications Limited has rescheduled the 75th meeting of its Committee of Creditors from August 21, 2026 to August 27, 2026. The company remains under corporate insolvency resolution process since June 2019, with the Resolution Professional managing its affairs. No financial figures or performance metrics were disclosed in this filing.
- · The company has been under corporate insolvency resolution process since June 28, 2019, following an NCLT order dated June 21, 2019.
- · The meeting was rescheduled from Friday, August 21, 2026 to Thursday, August 27, 2026.
- · The filing is made under Regulation 30 of SEBI LODR and sub-clause 16(g) of Clause A of Part A of Schedule III.
21-08-2026
Gabriel India Limited has executed the Joint Venture Agreement and Share Purchase Agreement to acquire a 30% minus one equity share stake in HL Klemove India Private Limited, making it an associate company. The transaction is expected to close on August 24, 2026. No financial terms or performance metrics were disclosed in this filing.
- · The acquisition is for 30% minus one equity share in HL Klemove India Private Limited.
- · The Joint Venture Agreement and Share Purchase Agreement were executed on August 21, 2026.
- · Consummation of the purchase is scheduled for August 24, 2026, unless otherwise mutually agreed.
- · Upon completion, HL Klemove India Private Limited will become an associate company of Gabriel India Limited.
21-08-2026
The National Company Law Tribunal (NCLT), Indore Bench, has admitted an application under Section 7 of the Insolvency and Bankruptcy Code, 2016, filed by Excellence Finance Pvt Ltd against Satiate Agri Ltd for a default of ₹6,27,09,615 (₹6.27 Cr) as of March 31, 2026. The company admitted the debt and default but cited temporary financial constraints and requested six months to repay, a plea the NCLT rejected. MVK IPE LLP has been appointed as the Interim Resolution Professional (IRP), initiating the Corporate Insolvency Resolution Process (CIRP).
- · The loan was secured by a pledge of shares of Aadi Chemtrade Limited held by the Corporate Debtor, with charge registered with the ROC.
- · The default date is 31.03.2026, and the application was filed on 02.06.2026.
- · The Corporate Debtor admitted the debt and default in its reply dated 27.07.2026, but sought six months' time to repay, which was rejected.
- · The NCLT order was pronounced on 20.08.2026 and made available on 21.08.2026.
- · The IRP's AFA (Authorisation for Assignment) is valid till 31.12.2026.
21-08-2026
The National Company Law Tribunal (NCLT), Chennai Bench, has admitted Gangotri Textiles Ltd's voluntary application under Section 10 of the Insolvency and Bankruptcy Code, 2016, initiating Corporate Insolvency Resolution Process (CIRP) against the company. The company defaulted on total financial debts of approximately ₹240,46,84,989 (₹240.46 Crore) as of the filing date, with the default originally dating back to October 24, 2005. The company's assets were sold by lenders in 2015, leaving it with no revenue source and mounting statutory liabilities, leading to the board's decision to seek insolvency.
- · NCLT Chennai Bench admitted CP(IB)/310(CHE)2025 on August 7, 2026, under Section 10 of IBC 2016.
- · The company was incorporated on July 26, 1989, with registered office in Coimbatore.
- · The default on financial debts dates back to October 24, 2005.
- · Lenders had sold the company's entire assets including nine manufacturing units, five wind mills, and three vacant lands in 2015, with proceeds adjusted against loan dues.
- · The company's shareholders passed a special resolution on December 15, 2023, approving the initiation of CIRP.
- · Statutory liabilities include demands from Customs, Income Tax, Sales Tax departments, and penalties/exchange fees from NSE and BSE.
- · As of May 31, 2025, the company's total equity and liabilities stood at ₹152,00,30,041, with negative reserves and surplus of ₹3,43,54,12,200.
- · Non-current assets total ₹51,94,25,026, primarily composed of non-current investments of ₹15,00,52,000.
- · Current liabilities amount to ₹2,30,77,16,245, mainly from short-term borrowings of ₹2,40,46,84,989.
21-08-2026
Liberty Broadband Corp filed an 8-K on August 21, 2026, reporting the termination of a material agreement and the adoption of new bylaws for a wholly owned subsidiary, Fusion Merger Sub 2, Inc., indicating an upcoming merger or acquisition. The filing includes standard corporate governance provisions for the merger subsidiary but provides no financial details or performance metrics.
- · The filing includes Items 1.02 (Termination of a Material Agreement), 2.01 (Completion of Acquisition or Disposition of Assets), 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule), 3.03 (Material Modification to Rights of Security Holders), 5.01 (Changes in Control of Registrant), 5.02 (Departure of Directors or Certain Officers), 5.03 (Amendments to Articles of Incorporation or Bylaws), and 9.01 (Financial Statements and Exhibits).
- · The bylaws establish the registered office at 251 Little Falls Drive, Wilmington, Delaware, with Corporation Service Company as registered agent.
- · The board of directors initially consists of one person and may be fixed thereafter by the board.
- · Stockholder meetings require a majority of voting power for a quorum; directors are elected by plurality vote.
21-08-2026
21-08-2026
KPI Green Energy Limited's subsidiary, Sun Drops Energia Limited, is acquiring up to 100% of DEK and Mavericks Green Energy Limited (DMGEL) for ₹55.80 Crore, to be paid via issuance of up to 15,89,781 Compulsorily Convertible Preference Shares (CCPS). The transaction is a related-party transaction to the extent of Promoter Dr. Faruk G. Patel's 8.95% stake in DMGEL and is expected to close by September 30, 2026. DMGEL's revenue has shown strong growth, increasing from ₹3062 Lakh in FY2023-24 to ₹21398 Lakh in FY2025-26, although this is based on a short operating history since its incorporation in November 2021.
- · The acquisition is a related-party transaction to the extent of the 8.95% stake held by Promoter Dr. Faruk G. Patel in DMGEL.
- · The valuation was supported by a report from Registered Valuer Mr. Abhishek Chhajed dated August 20, 2026.
- · DMGEL was incorporated on November 16, 2021, and has shown rapid revenue growth: ₹3062 Lakh in FY2023-24, ₹15004 Lakh in FY2024-25, and ₹21398 Lakh in FY2025-26.
- · The consideration will be settled through the issuance of up to 15,89,781 Compulsorily Convertible Preference Shares (CCPS) of Sun Drops, not cash.
- · The acquisition is expected to be completed by September 30, 2026, subject to shareholder approval and other compliances.
21-08-2026
Sandur Manganese & Iron Ores Limited has incorporated a wholly owned subsidiary, Royal Sandur Hospitality Private Limited, on August 21, 2026, to enter the hospitality business. The subsidiary was formed with a cash subscription of ₹1,00,00,000 for 10,00,000 equity shares of ₹10 each, representing 100% ownership by the parent. This strategic diversification moves the company beyond its core mining and ferroalloy operations into hospitality, including hotels, resorts, and restaurants.
- · The subsidiary is incorporated in India and operates in the hospitality industry.
- · The incorporation was approved by the Ministry of Corporate Affairs via a Certificate of Incorporation dated August 21, 2026.
- · The parent company holds 100% shareholding of the new subsidiary.
- · The subsidiary's business scope includes development, ownership, operation, and management of hotels, resorts, serviced apartments, restaurants, and allied establishments.
21-08-2026
Scan Projects Ltd has published newspaper advertisements in The Savera Times (English) and Dainik Savera Times (Hindi) on August 20, 2026, for the second motion application regarding its merger, inviting public objections or opposition. This is a procedural disclosure under SEBI LODR Regulations, 2015, and does not contain any financial figures or performance data.
- · Newspaper advertisements published on August 20, 2026 in The Savera Times (English) and Dainik Savera Times (Hindi).
- · The advertisement relates to the second motion application for the merger, inviting public objections or opposition.
- · The filing is made under Regulation 30 and Regulation 47 of SEBI (LODR) Regulations, 2015.
21-08-2026
Apollo Micro Systems Limited is making an open offer to acquire up to 1,39,77,911 equity shares (26% of equity capital) of Premier Explosives Limited at ₹698 per share. SEBI has permitted the tendering period to start within 12 working days of receiving Competition Commission of India approval, with payment to successful shareholders within 10 working days thereafter, subject to 10% per annum interest for any delay.
- · The open offer is made under Regulation 3(1) and 4 of SEBI (SAST) Regulations, 2011.
- · The Manager to the Open Offer is Cumulative Capital Private Limited.
- · SEBI's letter is dated August 21, 2026, and the company's disclosure is also dated August 21, 2026.
- · The tendering period cannot start until CCI approval is received.
- · Interest at 10% per annum applies if payment to shareholders is delayed beyond 10 working days from the last tendering date.
21-08-2026
21-08-2026
Hindalco Industries Limited, along with UltraTech Cement Limited and Grasim Industries Limited, incorporated a new associate company, UHG Holdings IFSC Private Limited, in GIFT City, Gujarat on August 20, 2026. The entity is a related party and will seek IFSCA approval to engage in aircraft, ship, and vessel leasing and operations. As a newly incorporated entity, it has no turnover or financial history, and the incorporation does not involve any acquisition consideration beyond the initial share subscription.
- · UHG Holdings was incorporated under CIN U64910GJ2026PTC182701.
- · The company will be governed by the International Financial Services Centres Authority Act, 2019 and IFSCA (Finance Company) Regulations, 2021.
- · Hindalco holds 50% shareholding, UltraTech Cement 41%, and Grasim Industries 9%.
- · The entity's object includes purchasing, leasing, chartering, hiring, owning, and operating aircraft, ships, ocean vessels, and other modes of transportation.
21-08-2026
OBCL Infrastructure Private Limited, a member of the promoter group of OBCL Limited (formerly Orissa Bengal Carrier Ltd.), acquired a total of 56,675 equity shares of the company through on-market transactions on August 19, 20, and 21, 2026. The acquisitions represent approximately 0.267% of the total paid-up equity capital of the company. This is a routine insider trading disclosure under SEBI regulations and does not reflect any change in control or a material corporate event.
21-08-2026
Shree Rajeshwaranand Paper Mills Ltd, undergoing Corporate Insolvency Resolution Process (CIRP), has approved the preferential allotment of 1,20,00,000 equity shares (face value ₹10 each) aggregating ₹12,00,00,000 (₹12 Cr) to 16 allottees, as part of the NCLT-approved Resolution Plan. Post-allotment, existing shareholders will be diluted to just 5%, while the RA/Affiliate/Nominee group will hold 95% of the company. The company will also apply for in-principle listing approval from BSE for these shares.
- · The NCLT Ahmedabad approved the Resolution Plan on 27th November 2024; certified copy received on 29th November 2024.
- · The preferential allotment was previously considered by the Board on 10th July 2025.
- · Largest allottee: Pratik Kakadia (65,00,000 shares, 51.35% post-allotment).
- · Second largest: Ramjibhai Kakadia (38,13,810 shares, 30.13% post-allotment).
- · Public shareholding will remain above 5% post-allotment.
- · Board meeting duration: 5:00 PM to 6:30 PM on 21st August 2026.
21-08-2026
Axita Cotton Limited has filed an Expression of Interest to participate in the Corporate Insolvency Resolution Process (CIRP) of Varidhi Cotspin Private Limited, a cotton yarn manufacturer with a spinning capacity of 29,184 spindles and 4,442 MTPA. The move is aimed at expanding Axita's presence across the cotton value chain, though the outcome of the CIRP process remains uncertain and no financial terms have been disclosed.
- · Varidhi Cotspin's manufacturing unit was established in 2017 and is located in Dholka, Ahmedabad, Gujarat.
- · Varidhi produces yarn for hosiery and weaving industries.
- · The acquisition is proposed under the Insolvency and Bankruptcy Code (IBC) process.
- · No financial details of the Expression of Interest or valuation have been disclosed.
21-08-2026
IRIS RegTech Solutions Limited (formerly IRIS Business Services Limited) has incorporated a wholly-owned subsidiary, IRIS Gulf Regulatory Technology L.L.C, in Dubai, UAE, following regulatory approval on August 20, 2026. The subsidiary, with an authorized share capital of AED 2,00,000, will establish a business presence in the UAE and Middle East to pursue SupTech and RegTech opportunities. The company will subscribe to 100% of the initial paid-up share capital for cash at face value of AED 10 per share.
- · The subsidiary was incorporated on August 20, 2026, with registration number 2914450 and membership number 698295.
- · The subsidiary is a related party transaction, but the subscription is at arm's length.
- · The industry of the subsidiary is RegTech / Financial Reporting Solutions / Supervisory Technology Solutions.
- · The cost of acquisition is at face value of AED 10 per share.
- · The company will hold 100% shareholding in the subsidiary.
21-08-2026
Promoter group entity Lalit Agrawal (HUF) acquired a total of 9,600 equity shares of Glen Industries Limited for ₹1,166,400 (₹11.66 Lakh) on August 20-21, 2026, at ₹121.50 per share. This increased the promoter and promoter group's aggregate shareholding from 74.17% to 74.21%. The transaction is a routine, small increase in promoter holding and does not represent an acquisition as defined.
- · Share price at which shares were acquired: ₹121.50 per share
- · The acquisitions were made at prevailing market price from public shareholders
- · Post-acquisition promoter & promoter group shareholding: 74.21%
- · Company confirmed compliance with minimum public shareholding requirements
21-08-2026
Grasim Industries Limited announced the incorporation of UHG Holdings IFSC Private Limited in GIFT City, Gujarat on August 20, 2026, as an associate company. The entity was jointly incorporated with UltraTech Cement Limited (subsidiary) and Hindalco Industries Limited (promoter group company), with Grasim holding a 9% stake for ₹90,000. UHG Holdings will focus on leasing and operating aircraft, ships, and ocean vessels under IFSC regulations, and will seek IFSCA approval.
- · UHG Holdings was incorporated under CIN U64910GJ2026PTC182701 on 20th August 2026.
- · The entity is governed by the International Financial Services Centres Authority Act, 2019 and IFSCA (Finance Company) Regulations, 2021.
- · UHG Holdings will seek approval from the International Financial Services Centres Authority (IFSCA).
- · The company has no turnover as it is a newly incorporated entity.
- · The object of UHG Holdings includes purchase, lease/sub-lease, charter, hire, own, operate aircraft, ships, ocean vessels, and other modes of transportation.
21-08-2026
Time Technoplast Limited (TTL) has convened a Board Meeting on August 26, 2026, to consider a proposal to merge its 74.86%-owned subsidiary TPL Plastech Limited into itself under Sections 230-232 of the Companies Act, 2013. The merger is subject to statutory and regulatory approvals. No financial details or timeline for completion have been disclosed in this intimation.
- · TTL operates manufacturing facilities across 11 countries including India, UAE, Bahrain, Saudi Arabia, Egypt, Malaysia, Thailand, Indonesia, Taiwan, Vietnam, and the USA.
- · TPL Plastech is listed on both BSE and NSE.
- · The merger will be carried out under Sections 230 to 232 of the Companies Act, 2013.
21-08-2026
The National Company Law Tribunal (NCLT), Chennai Bench-I, has sanctioned a Composite Scheme of Arrangement involving Veranda Learning Solutions Limited (VLS), its subsidiary Veranda XL Learning Solutions Private Limited (VXLS), and J.K. Shah Commerce Education Limited (JSCEL). The scheme involves the amalgamation of VXLS into VLS, followed by the demerger of VLS's Commerce Education Business into JSCEL, which will then be listed as a separate entity. The scheme received 100% approval from VLS equity shareholders who voted, and the NCLT order was uploaded on August 21, 2026.
- · The scheme was approved by the NCLT on August 20, 2026, and the order was uploaded on the NCLT website on August 21, 2026.
- · The first motion application was filed on January 27, 2026, and directions for shareholder meetings were issued on March 18, 2026.
- · The meeting of VLS equity shareholders was held on April 24, 2026, with remote e-voting open from April 20 to April 23, 2026.
- · Meetings of equity shareholders, secured creditors, and unsecured creditors of VXLS were dispensed with, as were meetings of secured creditors, unsecured creditors, and warrant holders of VLS.
- · Meetings of equity shareholders and unsecured creditors of JSCEL were also dispensed with.
- · The demerger is intended to unlock value and allow JSCEL to be listed as a separate entity focused on commerce education.
- · The scheme aims to consolidate operations, reduce costs, and improve cash management by amalgamating VXLS into VLS before the demerger.
21-08-2026
TPL Plastech Limited has informed the stock exchanges that its Board of Directors will meet on August 26, 2026, to consider and discuss a proposal for the merger of the company (Transferor Company) into its holding company, Time Technoplast Limited (Transferee Company), which holds a 74.86% stake in TPL. The merger is proposed under Sections 230 to 232 of the Companies Act, 2013, and is subject to all necessary statutory and regulatory approvals. No financial details or timeline for the merger have been disclosed in this intimation.
- · Board meeting scheduled for August 26, 2026.
- · Merger proposal is under Sections 230 to 232 of the Companies Act, 2013.
- · Time Technoplast Limited holds a 74.86% stake in TPL Plastech Limited.
- · The merger is subject to all necessary statutory and regulatory approvals.
21-08-2026
Kaiser Corporation Limited's board approved a Scheme of Amalgamation to merge Emazing Deals Limited into the company, subject to shareholder, creditor, NCLT, and stock exchange approvals. The board also appointed a registered valuer, merchant banker, and other professionals for the merger, and set the 33rd Annual General Meeting for September 28, 2026. No financial figures were disclosed in the filing, so no period-over-period comparisons are possible.
- · The board meeting commenced at 3:30 p.m. and concluded at 7:45 p.m. on August 21, 2026.
- · The Scheme of Amalgamation is subject to approval from shareholders, creditors, NCLT, and stock exchanges.
- · Mr. Nikhil P Chandak was appointed as Registered Valuer for the valuation report.
- · Navigant Corporate Advisors Limited was appointed as SEBI Registered Category 1 Merchant Banker for the fairness opinion report.
- · Mr. Asim Kumar Santara, Chartered Accountant, was appointed for the certificate of pricing of equity shares and networth certificate.
- · The 33rd Annual General Meeting is scheduled for Monday, September 28, 2026 at 11:30 a.m.
- · Book closure dates: September 22, 2026 to September 28, 2026 (both days inclusive).
- · E-voting period: 9:00 a.m. on September 25, 2026 to 5:00 p.m. on September 27, 2026.
- · Cut-off date for e-voting: September 21, 2026.
- · M/s Sameer Panchal & Associates appointed as Scrutinizer for the AGM e-voting.
- · Divya Mohta, Practicing Company Secretaries, appointed as Secretarial Auditor for five years (until 2031 AGM).
- · P. D. Chopda & Co., Chartered Accountants, appointed as Internal Auditors.
- · Ganesh & Rajendra Associates proposed as Statutory Auditors for five years (FY 2026-27 to 2030-31), subject to shareholder approval.
21-08-2026
Kaiser Corporation Limited's board approved a scheme of amalgamation with Emazing Deals Limited, where EDL will merge into Kaiser, subject to shareholder, creditor, NCLT, and stock exchange approvals. The board also appointed a registered valuer, merchant banker (Navigant Corporate Advisors), and other professionals for the merger, and set the 33rd Annual General Meeting for September 28, 2026. Additionally, new secretarial, internal, and statutory auditors were appointed for multi-year terms.
- · The board meeting started at 3:30 p.m. and concluded at 7:45 p.m. on August 21, 2026.
- · EDL provides plug-and-play e-commerce solutions covering marketplace integration, inventory management, order fulfillment, logistics, and customer service.
- · The scheme requires approval from respective shareholders, creditors, NCLT, and stock exchanges.
- · Registered valuer for the merger: Mr. Nikhil P Chandak.
- · Merchant banker for fairness opinion: Navigant Corporate Advisors Limited (SEBI registered Category 1).
- · Mr. Asim Kumar Santara appointed for pricing certificate and net worth certificate.
- · 33rd AGM scheduled for Monday, September 28, 2026, at 11:30 a.m.; book closure from September 22 to 28, 2026; e-voting from September 25 to 27, 2026; cut-off date September 21, 2026.
- · Scrutinizer: M/s Sameer Panchal & Associates, Practicing Company Secretaries.
- · Divya Mohta appointed secretarial auditor for a five-year term (up to 38th AGM in 2031).
- · P. D. Chopda & Co. appointed as internal auditors.
- · Ganesh & Rajendra Associates proposed as statutory auditors for FY 2026-27 to 2030-31, subject to shareholder approval.
21-08-2026
Forte Biosciences, Inc. filed Amendment No. 2 to its Schedule 14D-9 in connection with the tender offer by Avena Merger Sub Inc., a wholly owned subsidiary of argenx BV, to acquire all outstanding shares of Forte common stock for $77.00 per share in cash. The amendment provides supplemental disclosures, including updated financial projections through 2045, a discounted cash flow analysis using a discount rate range of 11.75%-14.50% and a terminal growth rate of -50.0% reflecting expected revenue decline after loss of exclusivity for FB102 in 2043, and a Guggenheim Securities fairness opinion fee estimated at $43 million. The company has received nine demand letters from shareholders alleging omitted material information, which the company believes are without merit; no lawsuits have been filed as of the filing date.
- · The company's financial projections cover fiscal years 2026 through 2045 and include risk-based adjustments.
- · Tax expense assumes a 25% rate and aggregate estimated cash savings from tax assets of approximately $153 million in fiscal years 2032 through 2034.
- · Guggenheim used a discount rate range of 11.75%-14.50% and a mid-year discounting convention with a valuation date of June 30, 2026.
- · Terminal value used a perpetual growth rate of negative 50.0%, reflecting continued revenue decline after assumed global loss of exclusivity for FB102 in 2043.
- · Diluted shares outstanding as of July 24, 2026 were based on 20.49 million basic shares outstanding plus dilutive impact of options, RSUs, pre-funded warrants, and ESPP purchase rights.
- · Wall Street equity research analyst stock price targets for the Company ranged from $54.00 to $75.00 per share, compared to the Offer Price of $77.00.
- · The company has received nine demand letters from shareholders but no lawsuits have been filed as of August 21, 2026.
- · No executive officers have reached definitive employment or retention agreements with the surviving corporation or parent as of the filing date, though discussions may occur before closing.
21-08-2026
VivoSim Labs, Inc. received a Nasdaq deficiency notice on August 17, 2026, for failing to maintain a minimum bid price of $1 per share over 30 consecutive business days. The company has 180 days, until February 16, 2027, to regain compliance, and is considering a reverse stock split (ratio 1-for-5 to 1-for-20) subject to stockholder approval. However, there is no assurance of regaining compliance, and failure could lead to delisting.
- · The company's common stock continues to trade on the Nasdaq Capital Market under symbol VIVS with no immediate effect on listing.
- · If compliance is not achieved by February 16, 2027, the company may be eligible for an additional 180-day compliance period if it meets other listing standards.
- · A reverse stock split proposal has been included in the preliminary proxy statement for the 2026 Annual Meeting of Stockholders, filed on August 10, 2026.
21-08-2026
Global Interactive Technologies, Inc. (GITS) received a Nasdaq notification on August 20, 2026, for failing to timely file its Form 10-Q for the quarter ended June 30, 2026, violating Nasdaq Listing Rule 5250(c)(1). The company has 60 days to submit a compliance plan and expects to file the Form 10-Q promptly. Its common stock continues to trade on Nasdaq during the grace period.
- · The company is an emerging growth company.
- · If Nasdaq accepts the compliance plan, the exception can extend until February 16, 2027.
- · The press release was issued on August 21, 2026.
21-08-2026
Citius Pharmaceuticals, Inc. (CTXR) received an extension from Nasdaq until February 8, 2027, to regain compliance with the $1.00 minimum bid price rule. The company must close at or above $1.00 for at least ten consecutive business days before that deadline to avoid delisting. While the stock continues to trade on the Nasdaq Capital Market, there is no assurance that compliance will be achieved.
- · The extension deadline is February 8, 2027.
- · Compliance requires the bid price to close at $1.00 or more for a minimum of ten consecutive business days.
- · If compliance is not regained by the deadline, Nasdaq will issue a delisting notice, and the company may appeal to a hearings panel.
- · The company is evaluating options to regain compliance but cannot guarantee success.
21-08-2026
QVC Group, Inc. filed Form 15 to terminate its SEC registration and reporting obligations after its stock was cancelled under a confirmed Chapter 11 reorganization plan. The company filed for bankruptcy on April 16, 2026, and the plan became effective on August 6, 2026, cancelling all outstanding shares of Series A and B common stock and preferred stock. This deregistration marks the final step in the company's emergence from bankruptcy with zero remaining holders of record.
- · The company filed for Chapter 11 bankruptcy on April 16, 2026, under case number 26-90447.
- · The reorganization plan was confirmed by the Bankruptcy Court on July 20, 2026.
- · The plan became effective on August 6, 2026, cancelling all outstanding shares.
- · The filing terminates registration under Section 12(g) and suspends reporting obligations under Sections 13(a) and 15(d).
21-08-2026
Bleichroeder Acquisition Corp. II entered into an amended advisory services agreement with MJP Advisory Group LLC, an affiliate of CEO Marcello Padula, on August 19, 2026. The agreement provides for a monthly fee of $18,000, a one-time closing fee of $1,850,000 upon completion of an initial business combination (the Pasqal Business Combination), or a liquidation fee of $600,000 if the company liquidates. No payments may be made from the trust account for public shareholders.
- · The A&R Agreement was approved by the Board of Directors on August 19, 2026.
- · Mr. Padula's appointment as CEO was effective April 29, 2026.
- · The Pasqal Business Combination Agreement was dated February 28, 2026, and involves Bleichroeder Acquisition France Merger Sub 2 and Pasqal Holding SAS.
- · If the company terminates without cause, MJP receives monthly fees for an additional six months (or until business combination, whichever is shorter) plus the applicable closing/liquidation fee.
- · No payments may be made from the trust account for public shareholders.
21-08-2026
Silexion Therapeutics Corp received a delisting notice from Nasdaq on August 18, 2026, for failing to meet the minimum shareholders' equity requirement of $2,500,000 under Listing Rule 5550(b)(1). As of June 30, 2026, the company reported shareholders' equity of only $44,000, and subsequent net losses have further eroded equity. The company intends to appeal the determination by August 25, 2026, but there is no assurance of success; failure could result in suspension of trading and removal of its securities from Nasdaq.
- · The company is under a Mandatory Hearings Panel Monitor per Nasdaq Listing Rule 5815(d)(4)(B) following a Panel decision dated September 23, 2025, which prevents the Nasdaq Listing Qualifications Department from granting additional time to regain compliance during the one-year monitoring period.
- · The company does not currently meet any of the alternative continued listing standards of The Nasdaq Capital Market.
- · The company's ordinary shares (SLXN) and warrants (SLXNW) are both listed on Nasdaq and would be subject to suspension and delisting if the appeal is unsuccessful.
21-08-2026
BioCardia, Inc. received a Nasdaq notice on August 19, 2026, for failing to maintain the minimum $1.00 bid price per share for 30 consecutive business days. The company has 180 calendar days (until February 16, 2027) to regain compliance by having a closing bid price of $1.00 or more for at least ten consecutive business days. While the notice has no immediate effect on trading, failure to cure could lead to eventual delisting, though additional time or a reverse stock split may be pursued.
- · Minimum bid price requirement: $1.00 per share for continued listing on Nasdaq Capital Market.
- · Compliance can be achieved if closing bid price is $1.00 or more for ten consecutive business days by February 16, 2027.
- · If not cured by February 16, 2027, the company may qualify for an additional 180-day compliance period if it meets other listing standards and intends to effect a reverse stock split.
- · If delisting occurs, the company can appeal to a Nasdaq hearings panel.
21-08-2026
loanDepot, Inc. received a NYSE notice on August 21, 2026, for non-compliance with the minimum share price rule (average closing price below $1.00 over 30 consecutive trading days). The company has a six-month cure period to regain compliance, during which the stock remains listed. The notice does not affect business operations or SEC reporting obligations, but failure to cure could lead to suspension and delisting.
- · The company must notify the NYSE of its intent to cure within 10 business days of the notice.
- · Compliance can be regained if on the last trading day of any calendar month during the cure period, the stock closes at or above $1.00 and has a 30-day average closing price of at least $1.00.
- · If the cure requires shareholder approval, the company must obtain it by the next annual meeting and implement the action promptly.
21-08-2026
Rain Enhancement Technologies Holdco, Inc. (RAIN/RAINW) received a delisting notice from Nasdaq on August 18, 2026, after failing to regain compliance with the $35 million market value of listed securities (MVLS) requirement within the 180-day cure period ending August 17, 2026. The company has timely requested a hearing before the Nasdaq Hearings Panel, which will stay any suspension or delisting pending the hearing, but there is no assurance the panel will grant continued listing relief.
- · Initial MVLS notice received on February 18, 2026, for 30 consecutive business days ended February 17, 2026.
- · Cure period expired on August 17, 2026; company failed to regain compliance.
- · Suspension and delisting scheduled for August 27, 2026, if no hearing request.
- · Hearing request submitted on August 21, 2026, stays delisting pending hearing outcome.
- · Company is considering all options to regain compliance.
21-08-2026
JAB Acquisition Corp I entered into a trademark settlement agreement on August 17, 2026, to resolve a claim regarding its name and trading symbol. As a result, the company plans to change its ticker symbols to ATLQ, ATLQU, ATLQW, and ATLQR and intends to rename itself Atlantic Acquisition Corp I, subject to board and shareholder approval. No action is required from shareholders, and the capital structure remains unchanged.
- · The settlement was with an unnamed third party (Claimant) to resolve an outstanding trademark claim.
- · New ticker symbols are expected to be ATLQ (ordinary shares), ATLQU (units), ATLQW (warrants), and ATLQR (rights).
- · Name change to Atlantic Acquisition Corp I requires both board and shareholder approval.
- · The company's CIK number will remain unchanged after the ticker change.
21-08-2026
ReNew Energy Global plc (RNWWW) received a delisting notice from Nasdaq Stock Market LLC, filed on August 21, 2026, for its warrants expiring August 22, 2026. The delisting is based on SEC Rule 17 CFR 240.12d2-2(a)(2), which typically applies when the entire class of securities is redeemed, matured, or has reached its expiration date. This is a routine administrative action tied to the natural expiration of the warrants, not a forced delisting due to non-compliance.
- · The delisting is effective as of August 21, 2026.
- · The warrants expire on August 22, 2026.
- · The filing is made under SEC Rule 17 CFR 240.12d2-2(a)(2).
- · The company's SEC file number is 001-40752.
- · The company was formerly known as ReNew Energy Global Ltd (name changed March 2, 2021).
21-08-2026
TruGolf Holdings, Inc. (TRUG) received a Nasdaq delisting notice on August 19, 2026, for failing to meet the minimum $2.5 million stockholders' equity requirement, reporting only $2,060,281. The company has until October 5, 2026, to submit a compliance plan, with a possible extension to February 15, 2027. Meanwhile, the company is proceeding with the acquisition of Polymath Research Inc. via amalgamation, and a significant conversion of Series A preferred stock into common shares has occurred, with 2,688,750 shares issued and approximately $4.4 million in stated value still outstanding, which could further dilute existing shareholders.
- · The company has 45 calendar days (until October 5, 2026) to submit a compliance plan to Nasdaq.
- · If the plan is accepted, Nasdaq can grant an extension of up to 180 calendar days (until February 15, 2027) to evidence compliance.
- · The Series A preferred stock conversion price was reset to $1.00 per share.
- · The company's Class A common stock will continue trading under symbol 'TRUG' during the process.
- · There is no assurance that the company will regain compliance or maintain other listing requirements.
21-08-2026
Pasithea Therapeutics Corp. (KTTAW) disclosed on August 21, 2026 that it received a notice from Nasdaq on August 20, 2026 granting a 180-day extension to February 16, 2027 to regain compliance with the minimum $1.00 bid price requirement for continued listing on the Nasdaq Capital Market. The company previously failed to meet the Minimum Bid Price Requirement and its initial 180-day grace period ended August 19, 2026. While the extension provides temporary relief, there is no assurance the company will regain compliance, and failure to do so would result in delisting proceedings.
- · Company first received a non-compliance notice on February 20, 2026, triggering a 180-day grace period ending August 19, 2026.
- · The extension pushes the compliance deadline to February 16, 2027.
- · Company may consider a reverse stock split to regain compliance.
- · If compliance is not regained by February 16, 2027, Nasdaq will issue a delisting notice; company may appeal to a Nasdaq hearings panel.
- · Common stock trades under symbol KTTAW on the Nasdaq Capital Market.
21-08-2026
Elutia completed the sale of its SimpliDerm business to Cellution Biologics for up to $11 million, receiving $8 million at closing and up to $3 million in milestone payments over 18 months. The divestiture adds non-dilutive capital to fund the development and commercial launch of NXT-41x, an antibiotic-eluting biomatrix targeting the $1.5 billion U.S. plastic and reconstructive surgery market. However, the company remains dependent on a narrower product set and faces risks from regulatory clearance (expected first half of 2027) and commercial execution.
- · NXT-41x is designed to provide soft-tissue reinforcement while locally delivering antibiotics to inhibit bacterial colonization at the surgical site.
- · Elutia plans to first commercialize NXT-41x in plastic/reconstructive surgery, then expand into general and oncologic surgeries.
- · The company believes it has sufficient funding to support operations through the first full year of NXT-41x commercial launch in 2028.
- · The sale was led by Dr. Sonali Fonseca, Vice President of Emerging Business.
21-08-2026
Dragonfly Energy Holdings Corp. received a Nasdaq deficiency notice on August 20, 2026, for failing to meet the minimum stockholders' equity requirement of $2.5 million, reporting a negative equity of $(184,000) as of June 30, 2026. The company also did not meet alternative compliance standards based on market value of listed securities ($35 million) or net income from continuing operations ($500,000). The company has 45 days (until October 5, 2026) to submit a compliance plan, and if accepted, Nasdaq may grant an extension until February 16, 2027; however, there is no assurance of acceptance or future compliance.
- · The company's common stock (DFLI) and warrants (DFLIW) continue to trade on Nasdaq pending the compliance process.
- · If Nasdaq rejects the plan, the company has the right to appeal to a Nasdaq hearings panel.
- · The company is an emerging growth company and has not elected the extended transition period for new accounting standards.
21-08-2026
authID Inc. received a deficiency notice from Nasdaq on August 18, 2026, for failing to meet the minimum stockholders' equity requirement of $2,500,000 under Listing Rule 5550(b)(1). The company reported stockholders' equity of only $2,042,515 as of June 30, 2026, and also does not satisfy the alternative market value or net income tests. While the stock continues to trade under the symbol AUID, the company has 45 days (until October 2, 2026) to submit a compliance plan, and there is no assurance that Nasdaq will accept the plan or that compliance can be regained.
- · The deficiency notice has no immediate effect on the listing or trading of AUID common stock.
- · If Nasdaq rejects the plan or compliance is not regained within the extension, the company may appeal to an independent Nasdaq Hearings Panel, which could grant an additional 180 days.
- · The filing includes a cautionary note about forward-looking statements, highlighting risks such as the ability to raise additional capital and substantial doubt about going concern.
21-08-2026
Estrella Immunopharma, Inc. received a Nasdaq deficiency notice on August 17, 2026, for failing to maintain a minimum bid price of $1.00 per share for its common stock (ESLA) for 30 consecutive business days. The company has until February 16, 2027, to regain compliance, and its stock continues trading in the interim. Failure to cure could lead to delisting.
- · The company may be eligible for an additional 180-day compliance period if it meets other listing standards.
- · If a reverse stock split is used to regain compliance, it must be completed at least 10 business days before the compliance deadline.
- · The company's stock symbols are ESLA (common stock) and ESLAW (warrants).
- · Warrants have an exercise price of $11.50 per share.
21-08-2026
Adial Pharmaceuticals received a Nasdaq notice on August 18, 2026, for failing to meet the minimum stockholders' equity requirement of $2.5 million for continued listing on the Nasdaq Capital Market. The company has 45 days (until October 2, 2026) to submit a compliance plan and intends to seek stockholder approval to convert its Series A Preferred Stock to regain compliance, but there is no assurance of success. If the plan is accepted, Nasdaq may grant an extension of up to 180 days; if not, the company faces potential delisting.
- · The company also does not meet the alternative quantitative standards: market value of listed securities of $35 million or net income from continuing operations of $500,000 in the most recently completed fiscal year or in two of the last three fiscal years.
- · The Notice has no immediate effect on trading; the stock remains listed pending compliance efforts.
- · If the compliance plan is not accepted or fails, the company can request a hearing before Nasdaq's Hearing Panel, which would stay any suspension or delisting action pending the hearing process.
21-08-2026
SolarMax Technology, Inc. (SMXT) received a Nasdaq notice on August 20, 2026, for failing to file its Form 10-Q for the quarter ended June 30, 2026, violating Listing Rule 5250(c)(1). The company has 60 days (until October 19, 2026) to submit a compliance plan, with a possible extension to February 16, 2027. This is the third Nasdaq deficiency notice in 2026, adding to prior failures to meet the minimum bid price of $1.00 (deadline August 31, 2026) and the market value of listed securities requirement of at least $35 million (deadline December 21, 2026). The company effected a 1-for-12 reverse stock split on August 13, 2026, to address the bid price issue, but the cumulative listing challenges signal significant financial and operational distress.
- · The company has received three separate Nasdaq deficiency notices in 2026: for failure to file Form 10-Q (June 30, 2026 quarter), for minimum bid price below $1.00 (deadline August 31, 2026), and for market value of listed securities below $35 million (deadline December 21, 2026).
- · The reverse stock split (1-for-12) was effected on August 13, 2026, to address the bid price deficiency.
- · If Nasdaq accepts the compliance plan, the company could have until February 16, 2027 to regain full compliance with the filing requirement.
21-08-2026
Flash Sports & Media Holdings, Inc. (formerly urban-gro, Inc.) received a Staff Determination from Nasdaq on August 19, 2026, stating that its securities are subject to immediate suspension due to the timing and sequencing of its initial listing application process following a reverse merger and conversion of Series B Preferred Stock into 53,539,119 common shares. The company intends to request a hearing before a Nasdaq Hearings Panel by August 26, 2026, to seek reinstatement, but trading is set to be suspended at the opening of business on that same day. The delisting risk could adversely affect the liquidity and market price of the company's common stock.
- · The reverse merger was completed on February 17, 2025.
- · Nasdaq Staff determined on February 24, 2026, that the transaction constituted a 'Change of Control' under Nasdaq Listing Rule 5110(a).
- · Stockholders approved removal of the 19.9% conversion cap on June 12, 2026.
- · Conversion of Series B Preferred Stock occurred on June 23, 2026.
- · The Staff Determination concerns only the timing/sequencing of the listing application, not a substantive deficiency with the company or its business.
- · Trading suspension is scheduled for the opening of business on August 26, 2026.
- · The hearing request deadline is 4:00 p.m. Eastern Time on August 26, 2026.
21-08-2026
K&F Growth Acquisition Corp. II received a Nasdaq deficiency notice on August 19, 2026, for failing to meet the minimum 400 total holders requirement for continued listing on the Nasdaq Global Market. The company has 45 days to submit a compliance plan and may be granted up to 180 days to cure the deficiency, or it may consider transferring to the Nasdaq Capital Market. The notice does not currently affect trading, and shares continue to trade under the symbol KFII.
- · The company has 45 calendar days from August 19, 2026 to submit a plan to regain compliance.
- · If Nasdaq accepts the plan, an extension of up to 180 calendar days may be granted.
- · The company may alternatively apply to transfer its securities to the Nasdaq Capital Market.
- · The company is an emerging growth company and has not elected to use the extended transition period for new financial accounting standards.
Get daily alerts with 10 investment signals, 10 risk alerts, 9 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Global High-Priority Regulatory Events
🇺🇸 More from United States
View all →August 24, 2026
US Pre-Market SEC Filings Roundup — August 24, 2026
US Pre-Market SEC Filings Roundup
August 24, 2026
US Merger & Acquisition SEC Filings — August 24, 2026
US Merger & Acquisition SEC Filings
August 24, 2026
USA Insider Trading Pulse — August 24, 2026
USA Insider Trading Pulse
August 22, 2026
New Drug Approvals (Original) — August 22, 2026
New Drug Approvals (Original)